Hydrocortisone probutate

丁丙氢化可的松

Report date: 2025/05/15 20:00:08
NME

Base Information

Drug NameHydrocortisone probutate
Drug Alias NameHydrocortisone Butyrate PropionatePandel
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsAdrenal InsufficiencyPruritusDermatitis
Global Approved IndicationsAdrenal InsufficiencyPruritusDermatitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/02/28
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaDiscontinued
Originator CompaniesFougera Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAdrenal InsufficiencyPruritusDermatitis

Other Information

ATC CodeA01AC03A07EA02C05AA01 +[9